LALD Introduction Patient Case Presentation.

Slides:



Advertisements
Similar presentations
Where Are We on the Path to Elimination of Chronic Hepatitis C?
Advertisements

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.
Upfront Combination Therapy vs Step-Up Approach for PAH:
Symptom Control and Enhancing Functioning in Schizophrenia
Poster Presentation Title
Sebelipase alfa Protein chemical formula : C1968H2945N507O551S15
A practical fluorometric assay method to measure lysosomal acid lipase activity in dried blood spots for the screening of cholesteryl ester storage disease.
Lysosomal Acid Lipase Deficiency: Paving the Path for an Early Diagnosis.
HCV. The Spectrum of Hepatitis C Virus Infection: From Acute Infection to End-Stage Liver Disease.
Improving the Diagnosis and Treatment of Seizures in Long-term Care
Maximizing Medical Management of Knee Osteoarthritis
Optimizing Outcomes in Short Bowel Syndrome With IF
EHRs and HIPAA: Steps to Maintain Privacy and Security of Patient Data
Allergy Testing in Children
Challenges in the Diagnosis of MS: Physician and Nurse Perspectives
Modifying Disease Course in Alzheimer's Disease
The Patient Journey to Remission in MDD: A Collaborative Approach
Epilepsy Treatment Across the Spectrum
Patient 1: 53-Year-Old Man With CVD Risk Factors
Ask the Onychomycosis Expert, Part 2
Renal and Extrarenal Complications of ADPKD: Facilitating Better Patient Care.
Clinical Review.
The Role of Imaging in Diagnosing IPF Hands-On Case Studies
Hunter Syndrome: Why We Need to Diagnose and Treat Early
Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.
Chronic Idiopathic Urticaria
What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?
Improving Risk Assessment and Early Diagnosis in PAH
Updates in Neuronal Ceroid Lipofuscinosis
SIBM: Epidemiology. sIBM: Epidemiology Disease Characteristics: Distinctive Patterns of Muscle Involvement.
Lysosomal Storage Disorders: Optimizing the Transition From Child to Adult Care.
Tuberous Sclerosis Complex Fundamental Concepts in Diagnosis and Management.
Approaches to the Patient With a Runny Nose
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Care of the Treatment-naive Patient With HCV/HIV Coinfection
Program Goals. Program Goals Introduction Causes of Hypoparathyroidism.
Diagnosing Nontuberculous Mycobacterial Disease
Expert Debate in MDD.
Program Goals. Program Goals Introduction Causes of Hypoparathyroidism.
Introduction. Exploring Strategies for Recognition and Management of Lower Limb Spasticity in Children.
Best Practices in the Identification and Management of Alzheimer Agitation.
Introduction to AD. Practical Approaches to the Identification of Alzheimer Disease in Primary Care.
Program Goals. Accurate Diagnosis and Treatment of Patients With Thrombotic Microangiopathy.
Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.
Program Goals Overview Is NEDA a Reasonable Target?
Volume 59, Issue 3, Pages (September 2013)
Managing Age-Related Clinical Issues in Hemophilia
Updates in Neuronal Ceroid Lipofuscinosis
Transitional Care of Patients With Hepatic Encephalopathy
Lysosomal Acid Lipase Deficiency: Paving the Path for an Early Diagnosis.
Lysosomal Acid Lipase Deficiency: Paving the Path for an Early Diagnosis.
Treating Atypical Hemolytic Uremic Syndrome A Case Discussion
Live on PAH: Breathing Life Into Patients With PAH
Practical Strategies for Getting Patients With Diabetes to Lipid Goal
Program Goal. Program Goal Disclaimer Overview.
The ABCs of Diagnosing Tardive Dyskinesia
Optimizing Front-Line Endocrine Therapy in Metastatic Breast Cancer
AMD Therapy: Where Are We Now and Where Are We Going?
Lysosomal Storage Disorders: Optimizing the Transition From Child to Adult Care.
PAH Pathways: What Do the Data Tell Us?”
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Championing Evidence-Based Care in Patients With Acute Low Back Pain
Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.
Clinical Pearls in the Management of Patients With Advanced Non-Small Cell Lung Cancer.
The Building Blocks of Homocystinuria and Homocysteinemia Management
Identifying TRK Fusions in Head and Neck Cancer
The Nurse View.
My PAH Patient.
The Real Burden of Rosacea
Navigating the Journey
Presentation transcript:

LALD Introduction

Patient Case Presentation

Patient Case Physical Exam

Patient Case Laboratory Results

Patient Case Differential Diagnosisa

Lysosomal Acid Lipase An Overview

The LALD Spectrum Wolman’s Diseasea

The LALD Spectrum Cholesterol Ester Storage Diseasea

LALD Genetics, Epidemiology, and Functiona,b

LAL D Hepatic Manifestations

LAL D Diagnostic Challengesa

LALD Current Treatmenta,b

LALD in Clinical Practice

Testing for LALD

LAL D Treatment Future Directions

Conclusions

Abbreviations

Abbreviations (cont)

References

References (cont)